Abstract
Background
To study the epidemiology of patients with endogenous endophthalmitis in Denmark.
Material and methods
Retrospective and prospective case series of 59 eyes in patients with endogenous endophthalmitis in Denmark between 2000 and 2016.
Results
The age of the patients ranged from 28 to 90 years with a median of 66 years. Sixty-two percent of the eyes had a final VA (visual acuity) ≤ 0.1 while 8% had a final VA ≥ 1.0. Positive cultures were obtained in 51% of the cases from the blood and in 43% from the vitreous. Streptococcus species and Staphylococcus aureus were the most commonly identified microorganisms. The sources of endogenous endophthalmitis were diverse and were not identified in 36% of the patients. Diabetes (36%) was the most predisposing medical illness. A total of 15% of the patients died within the first year after surgery for endophthalmitis and half of the patients died during follow up. The mortality of patients was 22.6 times higher compared to a Danish background population. Culture positive patients had a higher mortality compared to culture negative patients.
Conclusions
Endogenous endophthalmitis is a heterogeneous condition which is reflected in the age, the visual outcome and the mortality of the patients. The epidemiology of the disease is very different in Scandinavia compared to Asia. The visual prognosis remains grave and the majority of the eyes lose useful vision.
Similar content being viewed by others
References
Vaziri K, Pershing S, Albini TA, Moshfeghi DM, Moshfeghi AA (2015) Risk factors predictive of endogenous endophthalmitis among hospitalized patients with hematogenous infections in the United States. Am J Ophthalmol 159(3):498–504. doi:10.1016/j.ajo.2014.11.032
Shrader SK, Band JD, Lauter CB, Murphy P (1990) The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome. J Infect Dis 162(1):115–120
Solborg Bjerrum S, Hamoudi H, Friis-Moller A, la Cour M (2016) A prospective study on the clinical and microbiological Spectrum of Endophthalmitis in a specific region in Denmark. Ophthalmologica Journal international d’ophtalmologie International journal of ophthalmology Zeitschrift fur Augenheilkunde 235(1):26–33. doi:10.1159/000441662
Binder MI, Chua J, Kaiser PK, Procop GW, Isada CM (2003) Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center. Medicine 82(2):97–105
Jackson TL, Eykyn SJ, Graham EM, Stanford MR (2003) Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases. Surv Ophthalmol 48(4):403–423
Greenwald MJ, Wohl LG, Sell CH (1986) Metastatic bacterial endophthalmitis: a contemporary reappraisal. Surv Ophthalmol 31(2):81–101
Wong JS, Chan TK, Lee HM, Chee SP (2000) Endogenous bacterial endophthalmitis: an east Asian experience and a reappraisal of a severe ocular affliction. Ophthalmology 107(8):1483–1491
Schiedler V, Scott IU, Flynn HW Jr, Davis JL, Benz MS, Miller D (2004) Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes. Am J Ophthalmol 137(4):725–731. doi:10.1016/j.ajo.2003.11.013
Connell PP, O’Neill EC, Fabinyi D, Islam FM, Buttery R, McCombe M, Essex RW, Roufail E, Clark B, Chiu D, Campbell W, Allen P (2011) Endogenous endophthalmitis: 10-year experience at a tertiary referral centre. Eye (Lond) 25(1):66–72. doi:10.1038/eye.2010.145
Solborg Bjerrum S, Kiilgaard JF, Mikkelsen KL, la Cour M (2013) Outsourced cataract surgery and postoperative endophthalmitis. Acta Ophthalmol 91(8):701–708. doi:10.1111/aos.12279
Christensen SR, Hansen AB, La Cour M, Fledelius HC (2004) Bilateral endogenous bacterial endophthalmitis: a report of four cases. Acta Ophthalmol Scand 82(3 Pt 1):306–310. doi:10.1111/j.1600-0420.2004.00236.x
Karmisholt MK, Hjort U, Knudsen LL, Schonheyder HC (2008) Candidaemia and risk of intraocular infection: a Danish hospital-based cohort study. Scand J Infect Dis 40(3):241–246. doi:10.1080/00365540701642120
Ness T, Pelz K, Hansen LL (2007) Endogenous endophthalmitis: microorganisms, disposition and prognosis. Acta Ophthalmol Scand 85(8):852–856. doi:10.1111/j.1600-0420.2007.00982.x
Chee SP, Jap A (2001) Endogenous endophthalmitis. Curr Opin Ophthalmol 12(6):464–470
Okada AA, Johnson RP, Liles WC, D’Amico DJ, Baker AS (1994) Endogenous bacterial endophthalmitis. Report of a ten-year retrospective study. Ophthalmology 101(5):832–838
Lim HW, Shin JW, Cho HY, Kim HK, Kang SW, Song SJ, Yu HG, Oh JR, Kim JS, Moon SW, Chae JB, Park TK, Song Y (2014) Endogenous endophthalmitis in the Korean population: a six-year retrospective study. Retina 34(3):592–602. doi:10.1097/IAE.0b013e3182a2e705
Connell PP, O’Neill EC, Amirul Islam FM, Buttery R, McCombe M, Essex RH, Roufail E, Lash S, Wolffe B, Clark B, Chiu D, Campbell W, Allen P (2010) Endogenous endophthalmitis associated with intravenous drug abuse: seven-year experience at a tertiary referral center. Retina 30(10):1721–1725. doi:10.1097/IAE.0b013e3181dd6db6
Cho H, Shin YU, Siegel NH, Yu HG, Sobrin L, Patel A, Durand ML, Miller JW, Husain D (2016) Endogenous Endophthalmitis in the American and Korean population: an 8-year retrospective study. Ocul Immunol Inflamm 1–8. doi:10.1080/09273948.2016.1195000
Acknowledgements
Grant support has been given from: Øjenfonden and Værn Om Synet.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
The Danish Association of the Blind and Fight for Sight Denmark provided financial support for this study. The sponsors had no role in the design or conduct of this research.
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent: Informed consent was obtained from all individual participants included in the prospective part of this study.
Rights and permissions
About this article
Cite this article
Bjerrum, S.S., la Cour, M. 59 eyes with endogenous endophthalmitis– causes, outcomes and mortality in a Danish population between 2000 and 2016. Graefes Arch Clin Exp Ophthalmol 255, 2023–2027 (2017). https://doi.org/10.1007/s00417-017-3760-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-017-3760-4